BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
BIOREGENX, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $3.88M
- P/E (TTM)
- –
- Dividend yield
- –
BIOREGENX, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Nutritional [Member] | $1.63M | $1.82M | – | – | 87.8% | -10.8% |
| Medical Testing [Member] | $207.93K | $587.62K | – | – | 11.2% | -64.6% |
| Wellness Devices [Member] | $25.42K | $186.30K | – | – | 1.4% | -86.4% |
| Other Sales [Member] | $884 | $3.20K | – | – | 0.0% | -72.4% |
| Findit Services [Member] | – | – | $42.16K | $197.45K | – | – |
| Sales Of Essential Oils [Member] | – | – | $0 | $1.14K | – | – |
By region
From the segment and revenue-disaggregation notes of Bioregenx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.